IOmx Therapeutics raised €65M in a Series B round in Oct 2021. The company is based in Munich, Germany. Investors in the round: Athos Service, M Ventures, MIG Capital and 2 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €65M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
